Sanofi appoints Gary Nabel CSO
This article was originally published in Scrip
Executive Summary
Sanofi has named Dr Gary Nabel senior vice-president, chief scientific officer and deputy to the president for global R&D, effective 3 December 2012. Dr Nabel will report to Dr Elias Zerhouni, president for global R&D. He joins Sanofi from the National Institutes of Health, where he served as director of the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases since 1999.